Literature DB >> 2096303

Demonstration of dopamine DA-1 receptor sites in rat juxtaglomerular cells by light microscope autoradiography.

F Amenta1, A Ricci.   

Abstract

The binding of the selective DA-1 receptor antagonist [3H]-SCH 23390 in sections of rat kidney was studied using combined in vitro biochemical radio-receptor assay and autoradiography. [3H]-SCH 23390 was bound to sections of rat kidney in a manner consistent with the labeling of DA-1 receptors with a dissociation constant value of 4.2 nmol/l and a Bmax value of 180.6 fmol/mg protein. Light microscope autoradiography revealed a dense accumulation of silver grains in juxtaglomerular cells and in proximal convoluted tubule cells. These findings suggest that the stimulation of renin release elicited by dopamine and DA-1 receptor agonists may be mediated by the activation of DA-1 receptors located on juxtaglomerular cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2096303     DOI: 10.1007/bf00175718

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  Autoradiographic localization of dopamine DA1 receptors in rat kidney with [3H]Sch 23390.

Authors:  T Huo; D P Healy
Journal:  Am J Physiol       Date:  1989-09

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.

Authors:  D Zdilar; Z Lacković
Journal:  Eur J Pharmacol       Date:  1989-05-02       Impact factor: 4.432

4.  Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release.

Authors:  A Kurtz; R Della Bruna; J Pratz; I Cavero
Journal:  J Cardiovasc Pharmacol       Date:  1988-12       Impact factor: 3.105

Review 5.  Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.

Authors:  M F Lokhandwala; R J Barrett
Journal:  J Auton Pharmacol       Date:  1982-09

6.  Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.

Authors:  F Montier; P Katchadourian; J Pratz; I Cavero
Journal:  J Cardiovasc Pharmacol       Date:  1989-05       Impact factor: 3.105

7.  The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.